The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2020

Filed:

Jan. 06, 2016
Applicant:

The University of Tokyo, Tokyo, JP;

Inventors:

Yuya Terashima, Tokyo, JP;

Kouji Matsushima, Tokyo, JP;

Etsuko Toda, Tokyo, JP;

Hiroaki Terasawa, Kumamoto, JP;

Sosuke Yoshinaga, Kumamoto, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/145 (2006.01); G16B 15/00 (2019.01); A61K 45/06 (2006.01); C12Q 1/32 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/145 (2013.01); A61K 45/06 (2013.01); C12Q 1/32 (2013.01); C12Y 102/01003 (2013.01); G01N 33/6863 (2013.01); G16B 15/00 (2019.02); G01N 2333/521 (2013.01); G01N 2333/7158 (2013.01); G01N 2500/02 (2013.01); G01N 2500/20 (2013.01);
Abstract

An agent according to the present invention comprises as an effective component any of (1) disulfiram, diethyldithiocarbamate, or a metal complex of diethyldithiocarbamate; (2) a pharmaceutically acceptable salt of (1); or (3) a solvate of (1) or (2), and is used for inhibition of interaction between CR2B or CCR5 and FROUNT protein, inhibition of macrophages, control of cells constituting a cancer microenvironment or inflammatory microenvironment, or enhancement of anticancer activity of an anticancer drug. It is also possible to provide a compound with a reduced side effect and an increased pharmacological effect by identifying a disulfiram derivative having a lower aldehyde dehydrogenase-inhibiting activity and a higher FROUNT-inhibiting activity among derivatives prepared by structural modification of disulfiram.


Find Patent Forward Citations

Loading…